Tanfac Industries Limited moves to reshape its capital structure

The EGM notice earmarks Rs 75.55 Crores of the Rs 99.41 Crores preferential issue for financing the R-32 refrigerant gas plant, while Rs 23.86 Crores is for general corporate purposes. The notice places both uses in FY27. ^[1]

†Derived from the EGM allocations and total issue size.

Alignment with the capex plan

Management subsequently described the R-32 project as a 20,000 MTPA HFC-32 refrigerant gas project costing approximately Rs 390 Crores, targeted for commissioning by the end of Q3 FY27. ^[2] On that basis:

• The project-specific Rs 75.55 Crores represents approximately 19.37% of the stated Rs 390 Crores project cost, derived from the two cited amounts.
• The full Rs 99.41 Crores preferential issue equals approximately 25.49% of the project cost, but this overstates direct project funding because nearly one-quarter of the issue is reserved for general corporate purposes.
• Accordingly, the preferential issue is a supplementary tranche rather than full project financing; the remaining R-32 requirement would be approximately Rs 314.45 Crores before considering other funding sources, derived from Rs 390 Crores less Rs 75.55 Crores.

The raise also fits within a broader fluorochemicals expansion programme. TANFAC had already completed a QIP of approximately Rs 250 Crores, while another industry report referred to an estimated Rs 495 Crores downstream fluorinated-chemicals facility. ^[3] However, the Rs 495 Crores figure is not reconciled in the cited material with management's later Rs 390 Crores R-32 project estimate; they may represent different project scopes. Therefore, the firm conclusion is narrower: the preferential issue directly funds the R-32 downstream project, but does not disclose a separate allocation for core hydrofluoric-acid capacity or other specialty-chemical projects.

Issue price: The preferential issue is priced at Rs 2,341 per share, which the BSE approval also identifies as the minimum permissible price. Therefore, the issue is at the approved floor/minimum price, with no disclosed premium over that minimum. ^{[4] [5]}

The filing excerpt does not reproduce the underlying SEBI ICDR formula inputs or provide a separately calculated statutory floor-price figure. Accordingly, it supports the conclusion that the issue price is not below the SEBI ICDR-compliant floor, but does not independently establish whether Rs 2,341 was exactly equal to, or above, the formula-derived floor.

Dilution impact: The company will issue 4,24,647 new equity shares to promoter and non-promoter investors. ^{[4] [5]} The dilution of existing shareholders, assuming they do not participate, is:

`Dilution = 4,24,647 / (pre-issue outstanding shares + 4,24,647)`

The exact percentage impact on existing public shareholding cannot be calculated from the cited filing because it does not state:

• pre-issue total shares outstanding;
• pre-issue number or percentage of shares held by the public; or
• the split of the new allotment between promoter and non-promoter investors.

Thus, the transaction will reduce the public shareholders’ percentage ownership through the enlarged equity base, but the precise public-shareholding dilution remains not quantified in the filing excerpt.

The equity issue would reduce Tanfac’s debt-to-equity ratio only after allotment and receipt of funds; the current in-principle approval does not itself change the reported balance sheet. The proposed issue is for 4,24,647 shares at Rs 2,341 each, implying a gross equity raise of approximately Rs 99.41 Crores, derived from the disclosed share count and issue price ^[5]. BSE’s approval is expressly in-principle and is not listing approval, so completion remains a condition to the balance-sheet impact ^[4].

Debt-to-equity impact

If pre-issue debt is `D` and book equity is `E`, and debt remains unchanged:

• Pre-issue D/E = `D / E`
• Post-issue D/E = `D / (E + Rs 99.41 Crores)`

The ratio would therefore decline by approximately `Rs 99.41 Crores / (E + Rs 99.41 Crores)` in percentage terms, assuming the full proceeds are retained as equity and not offset by new borrowing. A larger reduction would occur if the proceeds were used to repay debt; the benefit would be smaller if the company simultaneously raises debt for the project.

A pre-issue consolidated debt and book-equity figure is not reported in the cited material, so the absolute D/E ratio and its exact post-issue level cannot be calculated. The issue would also increase the equity share count and dilute existing shareholders; the face-value portion is only a small part of the total raise, with most proceeds representing securities premium.

Financing strategy

This is evidence of a change in incremental financing mix, but not yet proof of a wholesale departure from historical funding practice. The stated use of proceeds includes financing an R-32 refrigerant-gas plant and general corporate purposes ^[1]. Funding an expansion project through fresh equity can reduce the need to fund the entire investment through debt or accumulated operating cash, thereby preserving balance-sheet capacity for future requirements.

However, the historical comparison cannot be established from the cited disclosures: there is no sourced time series here showing how Tanfac previously funded capacity maintenance through internal accruals versus borrowings. The appropriate conclusion is therefore:

• Immediate balance-sheet direction: lower leverage after completion, all else equal.
• Strategic signal: a move toward external equity participation for expansion, alongside—not necessarily replacing—internal accruals and debt.
• Confidence level: moderate for a project-specific financing shift, low for claiming a permanent change in capital-allocation policy.
• Key qualification: the issue was reduced from an earlier reported proposal of Rs 173.49 Crores to approximately Rs 99.41 Crores ^[6], which is consistent with a more measured or phased capital plan rather than an aggressive equity-funded expansion program.